Discovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-Cell Lymphoma 2 (Bcl-2)

dc.contributor.authorKinarivala, Nihar
dc.contributor.authorPatel, Ronak
dc.contributor.authorBoustany, Rose Mary Naaman
dc.contributor.authorAl Ahmad, Abraham J.
dc.contributor.authorTrippier, Paul C.
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:37:53Z
dc.date.available2025-01-24T11:37:53Z
dc.date.issued2017
dc.description.abstractNeurodegenerative diseases share certain pathophysiological hallmarks that represent common targets for drug discovery. In particular, dysfunction of proteostasis and the resultant apoptotic death of neurons represent common pathways for pharmacological intervention. A library of aromatic carbamate derivatives based on the clinically available drug flupirtine was synthesized to determine a structure-activity relationship for neuroprotective activity. Several derivatives were identified that possess greater protective effect in human induced pluripotent stem cell-derived neurons, protecting up to 80% of neurons against etoposide-induced apoptosis at concentrations as low as 100 nM. The developed aromatic carbamates possess physicochemical properties desirable for CNS therapeutics. The primary known mechanisms of action of the parent scaffold are not responsible for the observed neuroprotective activity. Herein, we demonstrate that neuroprotective aromatic carbamates function to increase the Bcl-2/Bax ratio to an antiapoptotic state and activate autophagy through induction of beclin 1. © 2017 American Chemical Society.
dc.identifier.doihttps://doi.org/10.1021/acs.jmedchem.7b01199
dc.identifier.eid2-s2.0-85038354051
dc.identifier.pmid29110485
dc.identifier.urihttp://hdl.handle.net/10938/28911
dc.language.isoen
dc.publisherAmerican Chemical Society
dc.relation.ispartofJournal of Medicinal Chemistry
dc.sourceScopus
dc.subjectAnimals
dc.subjectAutophagy
dc.subjectCarbamates
dc.subjectCell line
dc.subjectDrug discovery
dc.subjectHumans
dc.subjectNeurons
dc.subjectNeuroprotection
dc.subjectNeuroprotective agents
dc.subjectProto-oncogene proteins c-bcl-2
dc.subjectRats
dc.subject(9h fluoren 9 yl)methyl[2 amino 6 [(4 fluorobenzyl)amino] pyridin 3 yl]carbamate
dc.subject1 chloroethyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subject2 chloroethyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subject2,2,2 trichloroethyl[2 amino 6 [(4 fluorobenzyl)amino]pyridin 3 yl]carbamate
dc.subjectAllyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subjectBenzyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subjectCarbamic acid derivative
dc.subjectEthyl 6 [3 (trifluoromethyl)benzylamino] 2 aminopyridin 3 ylcarbamate
dc.subjectEthyl [2 amino 6 [(3 methoxybenzyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl [2 amino 6 [(3 methylbenzyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl [2 amino 6 [(4 chlorobenzyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl [2 amino 6 [[4 (trifluoromethoxy)benzyl]amino]pyridin 3 yl]carbamate
dc.subjectEthyl(2 amino 6 [[[6 (trifluoromethyl)pyridin 3 yl]methyl]amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 (benzylamino)pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [(4 fluorophenethyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [(4 methoxybenzyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [(4 methylbenzyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [(naphthalen 2 ylmethyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [[2 (trifluoromethyl)benzyl)amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [[4 (trifluoromethyl)benzyl]amino]pyridin 3 yl]carbamate
dc.subjectEthyl[2 amino 6 [[4 [(trifluoromethyl)thio]benzyl]amino]pyridin 3 yl]carbamate
dc.subjectHexyl [2 amino 6 [(4 fluorobenzyl)amino]pyridin 3 yl]carbamate
dc.subjectIsobutyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subjectMethyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subjectNeuroprotective agent
dc.subjectPhenyl [2 amino 6 [(4 fluorobenzyl)amino]pyridin 3 yl]carbamate
dc.subjectProp 2 yn 1 yl[2 amino 6 [(4 fluorobenzyl)amino]pyridin 3 yl]carbamate
dc.subjectPropyl[2 amino 6 [(fluorobenzyl)amino]pyridin 3 yl)carbamate
dc.subjectTert butyl 6 (4 fluorobenzylamino) 2 aminopyridin 3 ylcarbamate
dc.subjectUnclassified drug
dc.subjectUnindexed drug
dc.subjectProtein bcl 2
dc.subjectApoptosis
dc.subjectArticle
dc.subjectControlled study
dc.subjectDrug mechanism
dc.subjectDrug synthesis
dc.subjectHuman
dc.subjectHuman cell
dc.subjectInduced pluripotent stem cell
dc.subjectPc12 cell line
dc.subjectPhysical chemistry
dc.subjectSh-sy5y cell line
dc.subjectAnimal
dc.subjectChemistry
dc.subjectCytology
dc.subjectDrug development
dc.subjectDrug effects
dc.subjectMetabolism
dc.subjectNerve cell
dc.subjectRat
dc.titleDiscovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-Cell Lymphoma 2 (Bcl-2)
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2017-8525.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format